Clinical trial
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in…
NCT00050960 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00050960 |
|---|---|
| Title | Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer |
| Official title | Randomized Phase III Trial Comparing Targretin Capsules/Carboplatin/Paclitaxel Versus Carboplatin/Paclitaxel in Chemotherapy-Naïve Patients With Advanced or Metastatic Non-Small Cell Lung Cancer |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Non-small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | bexarotene with carboplatin and paclitaxel, carboplatin and paclitaxel |
| Enrollment | 612 |
| Start date | May 1, 2002 |
| Primary completion | Jul 1, 2004 |
| Completion | Mar 1, 2005 |
| First posted | Jan 3, 2003 |
| Last update posted | Jul 13, 2012 |
| Countries | Austria, Canada, France, Germany, Spain, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: